# DESCRIPTION

## CROSS REFERENCE

- relate to prior applications

## BACKGROUND

- describe pancreatic ductal adenocarcinoma

## SUMMARY OF THE INVENTION

- introduce tumor treatment method
- describe inhibitor of QSOX1
- introduce isolated nucleic acids
- describe recombinant expression vectors
- describe pharmaceutical compositions
- introduce methods for identifying candidate compounds

## DETAILED DESCRIPTION OF THE INVENTION

- cite references
- define singular forms
- describe all embodiments
- introduce tumor treatment method
- motivate QSOX1 inhibitors
- define QSOX1
- describe subject
- define inhibitor of QSOX1
- describe inhibit
- describe tumor types
- assess QSOX1 expression
- describe techniques for analysis
- describe antigen capture assays
- describe tissue sample
- describe control
- describe standard concentration curve
- describe monitoring progress
- identify subjects with tumors
- measure QSOX1 expression
- describe non-limiting tumor types
- describe pancreatic tumor
- describe breast tumor
- describe estrogen receptor positive breast tumor
- describe Luminal B tumor
- describe treating tumors
- describe symptoms of pancreatic cancer
- describe symptoms of breast cancer
- limit tumor metastasis
- describe mechanism of action
- describe preferred embodiments
- describe nucleic acid inhibitors
- describe shRNA
- describe exemplary shRNA constructs
- describe modified nucleic acid inhibitors
- describe administration techniques
- describe pharmaceutical compositions
- describe routes of administration
- describe ocular delivery
- describe parenteral administration
- describe pharmaceutical carriers
- describe unit dosage forms
- define isolated nucleic acids
- describe nucleic acid sequences
- specify nucleic acid backbone analogues
- define isolated
- describe chemical synthesis
- describe recombinant expression vectors
- define comprising
- describe shRNA
- describe promoter
- describe expression vectors
- describe host cells
- describe transfection
- describe pharmaceutical compositions
- define pharmaceutically acceptable salt
- describe methods for identifying candidate compounds
- describe contacting tumor cells
- describe determining QSOX1 expression
- describe inhibit
- describe control
- describe determining QSOX1 activity
- describe methods for prognosing a tumor
- describe determining QSOX1 expression level
- describe comparing to control
- describe prognosing tumor progression
- describe over-express
- describe tissue sample
- describe control for QSOX1 expression
- describe non-limiting tumor types
- describe prognosing tumor progression

### Example 1

- introduce pancreatic ductal adenocarcinoma
- motivate QSOX1 research
- describe QSOX1 function
- summarize QSOX1 structure
- discuss QSOX1 localization
- describe QSOX1 alternative splicing
- motivate QSOX1 role in pancreatic cancer
- describe cell culture methods
- describe immunohistochemistry methods
- generate shRNA and lentiviruses
- transduce shRNA into tumor cell lines
- describe SDS-PAGE-Western blotting methods
- analyze QSOX1 knockdown
- describe MTT assay methods
- analyze cell proliferation
- describe Annexin V/Propidium Iodide apoptosis analysis
- analyze apoptosis
- describe gelatin zymography methods
- analyze MMP-2 and MMP-9 activity
- describe RNA isolation and cDNA synthesis methods
- describe qPCR methods
- analyze QSOX1-L, QSOX1-S, MMP-2, and MMP-9 expression
- describe Matrigel invasion assay methods
- analyze cell invasion
- discuss QSOX1 role in invasion and metastasis
- summarize QSOX1 knockdown effects
- conclude QSOX1 significance in pancreatic cancer
- introduce QSOX1 detection
- motivate immunohistochemistry and western blot
- describe QSOX1 expression in pancreatic tumor cell lines
- analyze QSOX1 expression in tumor and adjacent normal tissue
- summarize QSOX1 expression results
- motivate QSOX1 knockdown experiment
- describe QSOX1 knockdown using shRNA constructs
- analyze QSOX1 knockdown effects on tumor cell growth
- describe cell cycle and apoptosis analysis
- analyze cell cycle and apoptosis results
- motivate tumor cell invasion experiment
- describe invasion assay using Matrigel
- analyze invasion assay results
- motivate mechanism of invasion experiment
- describe gelatin zymography analysis
- analyze gelatin zymography results
- introduce pancreatic cancer
- motivate QSOX1 study
- summarize QSOX1 over-expression in pancreatic tumors
- describe QSOX1 protein suppression experiment
- analyze cell growth results
- discuss cell cycle regulation
- discuss apoptosis
- introduce invasion as a hallmark of cancer
- describe QSOX1 protein suppression and invasion experiment
- analyze invasion results
- introduce matrix metalloproteinases (MMPs)
- describe MMP activation mechanism
- describe gelatin zymography
- analyze gelatin zymography results
- describe western blot analysis
- analyze western blot results
- describe qPCR experiment
- analyze qPCR results
- discuss QSOX1 role in MMP activation
- discuss potential mechanisms of QSOX1-MMP interaction
- discuss implications for pancreatic cancer treatment
- introduce references
- list reference 1
- list reference 2
- list reference 3
- list reference 4
- list reference 5
- list reference 6
- list reference 7
- list reference 8
- list reference 9
- list reference 33

### Example 2

- design shRNAs for QSOX1 knockdown
- test shRNAs in pancreatic tumor cells

### Example 3

- validate QSOX1 as anti-neoplastic target in vivo

### Example 4

- evaluate QSOX1 protein expression in breast adenocarcinoma cell lines
- assess effects of QSOX1 knockdown on cell growth, cell cycle, apoptosis, invasion and matrix metalloproteinase activity
- validate pro-invasive function of QSOX1
- correlate QSOX1 expression with poor prognosis in patients with Luminal B breast cancer
- analyze QSOX1 transcript expression using GOBO algorithm
- determine QSOX1 expression in ER+ tumors compared to ERâˆ’ tumors
- perform Kaplan Meier analyses to determine association of QSOX1 expression with relapse free survival and overall survival
- correlate QSOX1 expression with increasing tumor grade
- evaluate QSOX1 expression by immunohistochemistry
- stain breast tumor tissue microarray with rabbit anti-QSOX1 polyclonal antibody
- score QSOX1 expression by board certified pathologist
- demonstrate pattern of increasing QSOX1 expression in invasive ductal carcinomas
- evaluate association of QSOX1 expression with ER+ tumors and high Ki-67 expression
- evaluate association of QSOX1 expression with HER2+ tumors or cytokeratin markers
- correlate QSOX1 expression with more aggressive ER+ tumors
- evaluate QSOX1 expression by Western Blot
- assess QSOX1 expression in human breast adenocarcinoma cell lines
- determine QSOX1-S protein expression in luminal-like cell lines
- evaluate QSOX1 expression in transformed normal MCF10A cells
- stably knock-down QSOX1 expression in MCF7, BT549 and BT474 cells
- assess QSOX1 protein expression following stable knock-down
- evaluate growth rates of shQSOX1-transduced cells
- perform MTT assay to evaluate cell proliferation
- perform Trypan blue staining to evaluate cell proliferation
- analyze cell cycle, apoptosis and autophagy
- evaluate effects of shQSOX1 on cell cycle
- evaluate effects of shQSOX1 on apoptosis and autophagy
- suppress QSOX1 expression in tumor cells
- evaluate effects of shQSOX1 on tumor cell invasion
- perform modified Boyden chamber assay
- evaluate effects of shQSOX1 on matrix metalloproteinase activity
- perform gelatin zymography to determine MMP-2 and -9 activity
- evaluate effects of shQSOX1 on MMP-2 and -9 protein levels
- evaluate effects of shQSOX1 on MMP-2 and -9 mRNA levels
- discuss correlation of QSOX1 expression with poor RFS and OS in Luminal B breast cancer
- discuss correlation of QSOX1 expression with ER+ breast tumor cells
- discuss correlation of QSOX1 expression with high Ki-67 expression
- discuss correlation of QSOX1 expression with increasing tumor grade
- discuss potential of QSOX1 as a therapeutic target
- introduce cell culture
- describe immunohistochemistry and scoring of staining intensity
- assess statistical relationship between QSOX1 IHC and molecular subtypes of breast cancer
- generate short hairpin RNA and lentiviruses production
- generate shQSOX1-transduced tumor cell lines
- perform SDS-PAGE-Western blotting
- perform MTT assay
- perform Trypan Blue Live/Dead Cell Growth Assay
- isolate RNA and synthesize cDNA
- perform quantitative real-time PCR
- perform Boyden Chamber and Invasion Recovery Assay
- perform Gelatin Zymography
- reference example 4
- describe QSOX1 protein structure
- describe QSOX1 function
- describe QSOX1 regulation
- describe QSOX1 in cancer
- describe QSOX1 in breast cancer
- describe QSOX1 in pancreatic cancer
- describe QSOX1 in prostate cancer
- describe QSOX1 in other cancers
- describe QSOX1 in cell signaling
- describe QSOX1 in cell growth and proliferation
- describe QSOX1 in cell migration and invasion
- describe QSOX1 in apoptosis
- describe QSOX1 in autophagy
- describe QSOX1 in angiogenesis
- describe QSOX1 in metastasis
- describe QSOX1 in cancer stem cells
- describe QSOX1 in tumor microenvironment
- describe QSOX1 in cancer therapy
- describe QSOX1 in cancer diagnosis
- describe QSOX1 in cancer prognosis

